These results indicate that ouabain affects the malignant progression of DLBCL by influencing the m6A demethylase ALKBH5 and the m6A-binding protein IGF2BP2, suggesting that ALKBH5 and IGF2BP2 may be potential targets of ouabain action. Here, ALKBH5 is linked to diffuse large B-cell lymphoma.